Company Filing History:
Years Active: 1998
Title: The Innovations of Tilman Voss
Introduction
Tilman Voss is a notable inventor based in Modling, Austria. He has made significant contributions to the field of biotechnology, particularly in the expression of proteins. His work has implications for medical research and therapeutic applications.
Latest Patents
Tilman Voss holds a patent for a process and vector for expressing alpha-interferon in E. coli. This patent, titled "Methods and vectors for expressing interferon-alpha (IFN-.alpha.) proteins in E. coli," provides a method for producing biologically active IFN-.alpha. polypeptides. The use of a vector that includes an IFN-.alpha. sequence fused to an E. coli heat-stable enterotoxin signal sequence (STII) under the control of the E. coli phosphatase (phoA) promoter allows for high levels of correctly-folded and processed proteins. He has 1 patent to his name.
Career Highlights
Tilman Voss is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work at the company has focused on advancing biopharmaceuticals and improving protein expression systems. His innovative approaches have contributed to the development of new therapeutic options.
Collaborations
Tilman has collaborated with notable colleagues such as Rudolf Hauptmann and Edgar Falkner. These collaborations have fostered a productive environment for research and innovation in the field of biotechnology.
Conclusion
Tilman Voss is a distinguished inventor whose work in protein expression has the potential to impact medical science significantly. His contributions to biotechnology continue to pave the way for advancements in therapeutic applications.